Biotech venture explores engineered canines for military roles
A biotech startup backed by Colossal Biosciences is developing genetically altered dogs for military applications. The effort is intended to reshape how the U.S. armed forces operate.
A startup with backing from Colossal Biosciences is exploring genetically altered dogs for military use, with the stated goal of changing how the U.S. armed forces carry out operations. The work sits at the intersection of animal genetics, biotechnology, and defense research, though the available material does not specify the methods, timeline, or intended roles.
If such research advances, military personnel could encounter new operational tools, while animal-welfare specialists and regulators may face questions about care, ethics, and oversight. The biotech sector could draw greater attention to genetic engineering’s defense applications, and public discussion may focus on how this work is governed.